Omada Health Overview
Omada Health Target Price
See Omada Health's analyst price targets ($28) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$19.24
Average Target Price
$27.71
44% upside
44% upside7 analysts in the last 4 months
High: $35 | Low: $24
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-11 | BarclaysSaket Kalia | $27 | 40.3% upside |  |
| 2026-08-12 | Robert W. BairdVikram Kesavabhotla | $25 | 29.9% upside | |
| 2026-08-10 | BTIGDavid Larsen | $35 | 81.9% upside | |
| 2026-08-07 | BMO Capital | $24 | 24.7% upside | |
| 2026-08-03 | BarclaysSaket Kalia | $25 | 29.9% upside | |
| 2026-07-21 | Canaccord Genuity | $28 | 45.5% upside | |
| 2026-07-17 | BTIG | $30 | 55.9% upside | |
| 2026-06-22 | Morgan StanleyCraig Hettenbach | $30 | 55.9% upside | |
| 2026-05-08 | Evercore ISI | $20 | 4% upside | |
| 2026-05-08 | Wells Fargo | $18 |  6.4% downside | |
| 2026-05-08 | Canaccord Genuity | $24 | 24.7% upside | |
| 2026-04-08 | Evercore ISIElizabeth Anderson | $15 | 22% downside | |
| 2026-01-16 | Goldman SachsDavid Roman | $26 | 35.1% upside | |
| 2026-01-09 | Goldman Sachs | $29 | 50.7% upside | |
| 2026-01-08 | Wells Fargo | $17 | 11.6% downside | |
| 2026-01-05 | BarclaysSaket Kalia | $22 | 14.3% upside | |
| 2025-12-18 | Morgan Stanley | $32 | 66.3% upside | |
| 2025-10-08 | Evercore ISIElizabeth Anderson | $27 | 40.3% upside | |
| 2025-09-05 | Robert W. Baird | $24 | 24.7% upside | |
| 2025-07-01 | Needham | $23 | 19.5% upside | |